Why the study?
Does streptozotocin-induced diabetes cause electrocardiographic and histopathological changes indicative of diabetic cardiomyopathy in rats?
Does streptozotocin-induced diabetes cause electrocardiographic and histopathological changes indicative of diabetic cardiomyopathy in rats?
Streptozotocin-induced diabetic rats exhibit specific electrocardiographic and histopathological changes that can serve as markers for diabetic cardiomyopathy.
Supports STZ rat model for diabetic cardiomyopathy research; leaves open human translation.
Diabetes is a clinical condition that is associated with insulin deficiency and hyperglycemia. Cardiomyopathy, retinopathy, neuropathy, and nephropathy are well known complications of the elevated blood glucose. Diabetic cardiomyopathy is a clinical disorder that is associated with systolic and diastolic dysfunction along with cardiac fibrosis, inflammation, and elevated oxidative stress. In this study, diabetes was induced by intraperitoneal injection of streptozotocin (STZ) 50 mg/kg. We determined the plasma levels of cardiac troponin-T (cTnT), and creatinine kinase MB (CK-MB) by ELISA. Diabetic rats showed abnormal cardiac architecture and increased collagen production. significant elevation in ST-segment, prolonged QRS and QT-intervals, and increased ventricular rate were detected. Additionally, diabetic rats showed a prolongation in P wave duration and atrial tachyarrhythmia was observed. Plasma levels of cTnT and CK-MB were elevated. In conclusion, these electrocardiographic changes (elevated ST-segment, prolonged QT interval, and QRS complex, and increased heart rate) along with histopathological changes and increased collagen formation could be markers for the development of diabetic cardiomyopathy in rats.
No takes yet. Share an insight, caveat, or question.
Youssef et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: